Literature DB >> 24599828

Effect of the arteriovenous access for hemodialysis on subendocardial viability ratio, pulse pressure and hospitalizations.

Ricardo Senos Vizinho1, Catarina Santos, Carlos Lucas, Teresa Adragão, José Diogo Barata.   

Abstract

BACKGROUND: In some patients the potential benefits of the arteriovenous (AV) access over catheter for hemodialysis seem to be outweighed by global cardiovascular status deterioration.
METHODS: We prospectively evaluated 44 pre-dialysis chronic kidney disease patients submitted to vascular access creation during a follow-up of 25 ± 9 months. We performed pulse wave analysis and biochemical assessment before and 2 months after AV access construction, and we registered premature vascular access thrombosis, and all-cause and cardiovascular hospitalizations throughout follow-up.
RESULTS: We found a statistically significant decrease in the subendocardial viability ratio (SEVR) and pulse pressure (PP) parameters after AV access creation while brain natriuretic peptide significantly increased. Receiver operating characteristic curve analysis identified SEVR ≤113 % evaluated 2 months after vascular access construction as the best cutoff value for predicting all-cause and cardiovascular hospitalizations. Kaplan-Meier analysis showed that a SEVR ≤113 % was associated with all-cause (p = 0.010) and cardiovascular (p = 0.029) hospitalizations; Cox regression analysis verified a 4.9-fold higher risk of all-cause hospitalization in patients with SEVR ≤113 % (p = 0.005).
CONCLUSION: To our best knowledge, this report indicates, for the first time, that despite the decrease in PP parameters, the creation of a vascular access for hemodialysis was also associated with a reduction of SEVR which predicted a worse clinical outcome. We argue that the decrease of pulse pressure after arteriovenous construction may reflect a new hemodynamic set-point after vascular access creation and may not indicate a protective cardiovascular effect.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24599828     DOI: 10.1007/s40620-014-0056-1

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  33 in total

1.  Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure.

Authors:  A P Guerin; J Blacher; B Pannier; S J Marchais; M E Safar; G M London
Journal:  Circulation       Date:  2001-02-20       Impact factor: 29.690

2.  Diastolic time fraction as a determinant of subendocardial perfusion.

Authors:  Dirk S Fokkema; Jurgen W G E VanTeeffelen; Simone Dekker; Isabelle Vergroesen; Johannes B Reitsma; Jos A E Spaan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-12-22       Impact factor: 4.733

Review 3.  Pulse wave analysis and pulse wave velocity: a critical review of their strengths and weaknesses.

Authors:  Justine Ina Davies; Allan D Struthers
Journal:  J Hypertens       Date:  2003-03       Impact factor: 4.844

4.  The impact of arteriovenous fistulas on aortic stiffness in patients with chronic kidney disease.

Authors:  Mihai S Utescu; Amélie LeBoeuf; Nadia Chbinou; Simon Desmeules; Marcel Lebel; Mohsen Agharazii
Journal:  Nephrol Dial Transplant       Date:  2009-06-09       Impact factor: 5.992

5.  Effect of closure of the arteriovenous fistula on left ventricular dimensions in renal transplant patients.

Authors:  E C van Duijnhoven ; E C Cheriex; J H Tordoir; J P Kooman; J P van Hooff
Journal:  Nephrol Dial Transplant       Date:  2001-02       Impact factor: 5.992

6.  Subendocardial viability ratio as an index of impaired coronary flow reserve in hypertensives without significant coronary artery stenoses.

Authors:  D Tsiachris; C Tsioufis; D Syrseloudis; D Roussos; I Tatsis; K Dimitriadis; K Toutouzas; E Tsiamis; C Stefanadis
Journal:  J Hum Hypertens       Date:  2011-01-13       Impact factor: 3.012

7.  Reduction of left ventricular diameter and mass after surgical arteriovenous fistula closure in renal transplant recipients.

Authors:  Philippe Unger; K Martin Wissing; Luc de Pauw; Jolanta Neubauer; Philippe van de Borne
Journal:  Transplantation       Date:  2002-07-15       Impact factor: 4.939

8.  The contribution of an arteriovenous access for hemodialysis to left ventricular hypertrophy.

Authors:  Yaacov Ori; Asher Korzets; Menachem Katz; Arie Erman; Talia Weinstein; Tsipora Malachi; Uzi Gafter
Journal:  Am J Kidney Dis       Date:  2002-10       Impact factor: 8.860

9.  The impact of arteriovenous fistula formation on central hemodynamic pressures in chronic renal failure patients: a prospective study.

Authors:  M Tessa Savage; Charles J Ferro; Antonio Sassano; Charles R V Tomson
Journal:  Am J Kidney Dis       Date:  2002-10       Impact factor: 8.860

10.  Relation between diastolic perfusion time and coronary artery stenosis during stress-induced myocardial ischemia.

Authors:  G Ferro; C Duilio; L Spinelli; G A Liucci; F Mazza; C Indolfi
Journal:  Circulation       Date:  1995-08-01       Impact factor: 29.690

View more
  4 in total

1.  Preserved Cardiac Blood Supply-Workload Balance in Pediatric Patients After Aortic Arch Repair.

Authors:  Tomoaki Murakami; Atsuhito Takeda
Journal:  Pediatr Cardiol       Date:  2017-10-27       Impact factor: 1.655

2.  Effects of Arteriovenous Fistula on Blood Pressure in Patients With End-Stage Renal Disease: A Systematic Meta-Analysis.

Authors:  Sean S Scholz; Davor Vukadinović; Lucas Lauder; Sebastian Ewen; Christian Ukena; Raymond R Townsend; Stefan Wagenpfeil; Michael Böhm; Felix Mahfoud
Journal:  J Am Heart Assoc       Date:  2019-02-19       Impact factor: 5.501

3.  Prehemodialysis arteriovenous access creation is associated with better cardiovascular outcomes in patients receiving hemodialysis: a population-based cohort study.

Authors:  Cheng-Chieh Yen; Mei-Yin Liu; Po-Wei Chen; Peir-Haur Hung; Tse-Hsuan Su; Yueh-Han Hsu
Journal:  PeerJ       Date:  2019-04-03       Impact factor: 2.984

4.  A new tonometric device for radial augmentation index and subendocardial viability ratio: potential use in health screening.

Authors:  Jing-Zhi Wang; Yong-Liang Zhang; Fu-Song Hu; Zi-Jun He; Xian-Jun Yang; Zu-Chang Ma; Yi-Ning Sun
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-09-09       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.